RISING STARS: Sex Differences in Toxicant-associated Fatty Liver Disease

Overview

Journal J Endocrinol

Specialty Endocrinology

Date 2023 Apr 19

PMID 37074385

Authors

Banrida Wahlang

Affiliations

Soon will be listed here.

Abstract

Based on biological sex, the consequential health outcomes from exposures to environmental chemicals or toxicants can differ in disease pathophysiology, progression, and severity. Due to basal differences in cellular and molecular processes resulting from sexual dimorphism of organs including the liver and additional factors influencing 'gene-environment' interactions, males and females can exhibit different responses to toxicant exposures. Associations between environmental/occupational chemical exposures and fatty liver disease (FLD) have been well-acknowledged in human epidemiologic studies and their causal relationships demonstrated in experimental models. However, studies related to sex differences in liver toxicology are still limited to draw any inferences on sex-dependent chemical toxicity. The purpose of this review is to highlight the present state of knowledge on the existence of sex differences in toxicant-associated FLD (TAFLD), discuss potential underlying mechanisms driving these differences, implications of said differences on disease susceptibility, and emerging concepts. Chemicals of interest include various categories of pollutants that have been investigated in TAFLD, namely persistent organic pollutants, volatile organic compounds, and metals. Insight into research areas requiring further development is also discussed, with the objective of narrowing the knowledge gap on sex differences in environmental liver diseases. Major conclusions from this review exercise are that biological sex influences TAFLD risks, in part due to (i) toxicant disruption of growth hormone and estrogen receptor signaling, (ii) basal sex differences in energy mobilization and storage, and (iii) differences in chemical metabolism and subsequent body burden. Finally, further sex-dependent toxicological assessments are warranted for the development of sex-specific intervention strategies.

Citing Articles

Concentrations of Serum Per- and Polyfluoroalkyl Substances and Lipid Health in Adolescents: A Cross-Sectional Study from the Korean National Environmental Health Survey 2018-2020.

Shin M, Kang H, Kim S Toxics. 2025; 13(2).

PMID: 39997906 PMC: 11860244. DOI: 10.3390/toxics13020091.

HDI-STARR-seq: Condition-specific enhancer discovery in mouse liver in vivo.

Chang T, Waxman D BMC Genomics. 2024; 25(1):1240.

PMID: 39716078 PMC: 11668083. DOI: 10.1186/s12864-024-11162-9.

Adipose tissue as target of environmental toxicants: focus on mitochondrial dysfunction and oxidative inflammation in metabolic dysfunction-associated steatotic liver disease.

Lolescu B, Lolescu B, Furdui-Linta A, Ilie C, Sturza A, Zara F Mol Cell Biochem. 2024; .

PMID: 39704874 DOI: 10.1007/s11010-024-05165-z.

Low dose exposure to dioxins alters hepatic energy metabolism and steatotic liver disease development in a sex-specific manner.

Bolatimi O, Hua Y, Ekuban F, Gripshover T, Ekuban A, Luulay B Environ Int. 2024; 194:109152.

PMID: 39577358 PMC: 11700233. DOI: 10.1016/j.envint.2024.109152.

HDI-STARR-seq: Condition-specific enhancer discovery in mouse liver in vivo.

Chang T, Waxman D bioRxiv. 2024; .

PMID: 38915578 PMC: 11195054. DOI: 10.1101/2024.06.10.598329.

References

Li R, Sun Q, Lam S, Chen R, Zhu J, Gu W . Sex-dependent effects of ambient PM pollution on insulin sensitivity and hepatic lipid metabolism in mice. Part Fibre Toxicol. 2020; 17(1):14. PMC: 7178763. DOI: 10.1186/s12989-020-00343-5. View

Sell S, Ilic Z . Dietary cadmium may enhance the progression of hepatocellular tumors in hepatitis B transgenic mice. Carcinogenesis. 1994; 15(9):2057-60. DOI: 10.1093/carcin/15.9.2057. View

Naville D, Pinteur C, Vega N, Menade Y, Vigier M, Le Bourdais A . Low-dose food contaminants trigger sex-specific, hepatic metabolic changes in the progeny of obese mice. FASEB J. 2013; 27(9):3860-70. DOI: 10.1096/fj.13-231670. View

Min G, Kim H, Bae Y, Petz L, Kemper J . Inhibitory cross-talk between estrogen receptor (ER) and constitutively activated androstane receptor (CAR). CAR inhibits ER-mediated signaling pathway by squelching p160 coactivators. J Biol Chem. 2002; 277(37):34626-33. DOI: 10.1074/jbc.M205239200. View

Muhetaer M, Yang M, Xia R, Lai Y, Wu J . Gender difference in arsenic biotransformation is an important metabolic basis for arsenic toxicity. BMC Pharmacol Toxicol. 2022; 23(1):15. PMC: 8883647. DOI: 10.1186/s40360-022-00554-w. View

Shaheen M, Schrode K, Pan D, Kermah D, Puri V, Zarrinpar A . Sex-Specific Differences in the Association Between Race/Ethnicity and NAFLD Among US Population. Front Med (Lausanne). 2021; 8:795421. PMC: 8674562. DOI: 10.3389/fmed.2021.795421. View

Smith A, Francis J, Dinsdale D, Manson M, Cabral J . Hepatocarcinogenicity of hexachlorobenzene in rats and the sex difference in hepatic iron status and development of porphyria. Carcinogenesis. 1985; 6(4):631-6. DOI: 10.1093/carcin/6.4.631. View

Cano R, Perez J, Angarita Davila L, Ortega A, Gomez Y, Valero-Cedeno N . Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review. Int J Mol Sci. 2021; 22(9). PMC: 8125512. DOI: 10.3390/ijms22094807. View

Roberts E, Sarkar B . Liver as a key organ in the supply, storage, and excretion of copper. Am J Clin Nutr. 2008; 88(3):851S-4S. DOI: 10.1093/ajcn/88.3.851S. View

10.

Cakmak S, Cole C, Hebbern C, Andrade J, Dales R . Associations between blood volatile organic compounds, and changes in hematologic and biochemical profiles, in a population-based study. Environ Int. 2020; 145:106121. DOI: 10.1016/j.envint.2020.106121. View

11.

Costello E, Rock S, Stratakis N, Eckel S, Walker D, Valvi D . Exposure to per- and Polyfluoroalkyl Substances and Markers of Liver Injury: A Systematic Review and Meta-Analysis. Environ Health Perspect. 2022; 130(4):46001. PMC: 9044977. DOI: 10.1289/EHP10092. View

12.

Grossmann M, Wierman M, Angus P, Handelsman D . Reproductive Endocrinology of Nonalcoholic Fatty Liver Disease. Endocr Rev. 2018; 40(2):417-446. DOI: 10.1210/er.2018-00158. View

13.

Meda C, Barone M, Mitro N, Lolli F, Pedretti S, Caruso D . Hepatic ERα accounts for sex differences in the ability to cope with an excess of dietary lipids. Mol Metab. 2020; 32:97-108. PMC: 6957843. DOI: 10.1016/j.molmet.2019.12.009. View

14.

Khazaee M, Guardian M, Aga D, Ng C . Impacts of Sex and Exposure Duration on Gene Expression in Zebrafish Following Perfluorooctane Sulfonate Exposure. Environ Toxicol Chem. 2019; 39(2):437-449. DOI: 10.1002/etc.4628. View

15.

Tarnow P, Tralau T, Luch A . Chemical activation of estrogen and aryl hydrocarbon receptor signaling pathways and their interaction in toxicology and metabolism. Expert Opin Drug Metab Toxicol. 2019; 15(3):219-229. DOI: 10.1080/17425255.2019.1569627. View

16.

Wahlang B, Falkner K, Gregory B, Ansert D, Young D, Conklin D . Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice. J Nutr Biochem. 2013; 24(9):1587-95. PMC: 3743953. DOI: 10.1016/j.jnutbio.2013.01.009. View

17.

Trefts E, Gannon M, Wasserman D . The liver. Curr Biol. 2017; 27(21):R1147-R1151. PMC: 5897118. DOI: 10.1016/j.cub.2017.09.019. View

18.

Martin M, Voeller H, Gelmann E, Lu J, Hebert E, Reiter R . Role of cadmium in the regulation of AR gene expression and activity. Endocrinology. 2001; 143(1):263-75. DOI: 10.1210/endo.143.1.8581. View

19.

Kim H, Kwack S, Sik Han E, Kang T, Kim S, Han S . Induction of apoptosis and CYP4A1 expression in Sprague-Dawley rats exposed to low doses of perfluorooctane sulfonate. J Toxicol Sci. 2011; 36(2):201-10. DOI: 10.2131/jts.36.201. View

20.

Chung S, Moon J, Yoon J, Won K, Lee H . The sex-specific effects of blood lead, mercury, and cadmium levels on hepatic steatosis and fibrosis: Korean nationwide cross-sectional study. J Trace Elem Med Biol. 2020; 62:126601. DOI: 10.1016/j.jtemb.2020.126601. View